Persist AI

Persist AI specializes in the development of microsphere formulations for drug delivery, leveraging AI-driven automation to significantly reduce formulation development time by 50%. The company serves pharmaceutical clients by optimizing drug loading, morphology, and distribution through the creation of up to 500 formulations per month. Persist AI's business model focuses on providing rapid pre-formulation services, completing PLGA microsphere pre-formulation in weeks rather than years. The company generates revenue by offering these specialized services to pharmaceutical companies looking to meet specific in vitro and in vivo drug release targets. With a team backed by over 15 years of expertise in drug formulation, machine learning, and automation, Persist AI is committed to exceeding customer expectations through strong teamwork and a supportive work environment. The company operates as a hybrid remote and local entity, fostering collaboration through annual team-building activities. Keywords: microsphere, drug delivery, AI-driven, automation, pharmaceutical, formulation, PLGA, machine learning, pre-formulation, scale-up.